Patent Assignment
Reel/Frame 025086/0523
Sponsored Research Agreement
Recorded: 2010-09-30
Pages: 28
Assignor
FIORUCCI, STEFANO
Executed: 2005-01-01
Assignee
INTERCEPT PHARMACEUTICALS, INC.
421 HUDSON STREET, SUITE 212, NEW YORK, NEW YORK, 10014
Covered Property
(1)
Bile Acid Derivatives as Fxr Ligands for the Prevention or Treatment of Fxr-Mediated Diseases or Conditions
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 30, 2010
From: PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025072/0095 →
Change of Address of Assignee
Oct 13, 2010
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025130/0816 →
Notice of Joint Ownership Claim
Mar 23, 2017
From: FIORUCCI, STEFANO, DR.
To: FIORUCCI, STEFANO, DR.
Reel/Frame 042072/0643 →
Security Interest
Aug 18, 2021
From: INTERCEPT PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 057650/0772 →
Change of Address
Aug 22, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 061297/0856 →
Release of Security Interest
Jan 4, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 066662/0210 →